carbidopa 35 MG / levodopa 140 MG Extended Release Oral Capsule
RxNorm concept 2690259, clinical drug (scd).
- RxCUI
- 2690259
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2690259 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
carbidopa 35 MG / L-DOPA 140 MG Extended Release Oral Capsule
Related concepts
- carbidopa 35 MG (SCDC, consists of)
- levodopa 140 MG (SCDC, consists of)
- Extended Release Oral Capsule (DF, has dose form)
- carbidopa 35 MG / levodopa 140 MG Extended Release Oral Capsule [Crexont] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2690259 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2690259 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2690259. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.